New Research Chem - ACE-031

[ErnieTaylor]

Any ideas when we will see this available?

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

ACE-031 is an investigational protein therapeutic that builds muscle and increases strength by inhibiting signaling through a cell surface receptor called activin receptor type IIB (ActRIIB). ACE-031 is a recombinant fusion protein that is produced by joining a portion of the human ActRIIB receptor to a portion of a human antibody. This creates a freely circulating, decoy version of ActRIIB which removes proteins, such as GDF-8 (myostatin), that limit the growth and regeneration of muscle. Animal studies with ACE-031 suggest that blocking signaling through ActRIIB leads to increased muscle mass and improved physical function in a range of animal models of muscle disease, including models of muscular dystrophy. ACE-031 is currently being studied in a phase 2 clinical trial of patients with Duchenne Muscular Dystrophy (DMD) who are also receiving corticosteroid therapy.

Anabolic Steroids Blog and BodyBuilding Blog | Dianabol Steroid Blog: Future bodybuilding drug ACE-031 coming soon thanks to FDA Orphan Designation.

 

[FIRE0808]

Sounds interesting.

 

[airspirit]

After reading the abstracts and whatnot on this I have a sneaking suspicion that this will become a basic part of cycles in the future. Read up on those cows that are missing GDF-8 naturally ... those are some swole cows. Putting this into a cycle and doing some heavy lifting could be utterly ridiculous.

 

[Bleed]

I really want to see what kind of side effects this gives. If not many and it performs as well as it sounds like it COULD, then this could be huge if the price point is right.

 

[Newman]

If only we had a sponsor who carried it... (sigh)

 

[Creation]

hmmmmmmmmm I like where this is going....